Obesity contributes to development of youth-onset type 2 diabetes (T2D) and can lead to detrimental health outcomes in adulthood. Researchers explored this relationship and offered insights on addressing the problem during a session at the American Diabetes Association’s (ADA) 80th Scientific sessions, held virtually due to coronavirus disease 2019 (COVID-19).
Obesity contributes to development of youth-onset type 2 diabetes (T2D) and can lead to detrimental health outcomes in adulthood. Researchers explored this relationship and offered insights on addressing the problem during a session at the American Diabetes Association’s (ADA) 80th Scientific sessions, held virtually due to coronavirus disease 2019 (COVID-19).
In the United States, obesity affects 1 in 5 children and adolescents, according to the CDC, while the risk of developing T2D is 4 times greater for obese children compared with those at normal weight.
The session began with a study comparing cerebral blood flow in obese youth with T2D and obese controls without T2D. Youth with T2D tend to have higher rates of vascular thickness and stiffness compared with peers with T1D, while youth onset T2D is associated with an increased risk of cardiovascular disease.
Using magnetic resonance imaging (MRIs), researchers found global cerebral blood flow was significantly lower in those with T2D compared with their obese euglycemic counterparts.1 Blood flow was lower in 7 regions in the brain throughout the parietal, frontal, and temporal lobes (P < .01), while there were no brain regions in which blood flow was greater in youth with T2D. Imaging also revealed carotid intima medial thickness (IMT) was inversely correlated with cerebral blood flow in the T2D cohort. Researchers suggest longitudinal studies take place using larger cohorts to investigate the association between cerebral blood flow, cognitive function, and brain structure.
In a study of 35 obese youth with a Body Mass Index (BMI) above the 85th percentile (age 15.8 [SD 2.4]) researchers investigated the metabolic and genetic determinants of incretin effects in those with normal (n=18) and impaired (n=17) glucose intolerance.2
Prediabetes and T2D in obese youth are associated with a reduced incretin effect, defined as a greater insulin response to an oral vs. intravenous glucose load.
Investigators found “insulin clearance (P = .004), T allele for TCF7L2 (P = .018) and 2-h glucose (P = .035) were independent determinants of the incretin effect, with an increase in insulin clearance associated with greater incretin effect.” The low-incretin phenotype in obese youths is characterized by reduced beta cell function after the oral glucose load, low insulin sensitivity and clearance, and a higher 1-hour (1-h) glucose.
By identifying the low-incretin effect phenotype, providers may be able to target therapeutic interventions based on glucagon-like peptin-1 (GLP-1) analogues. “The use of 1-h glucose might provide a convenient cost-effective surrogate measure to identify this group and to define its longitudinal progression,” researchers concluded.
A separate3 randomized treatment trial of T2D in youth evaluated lipoprotein particle distribution, as T2D in adolescents is associated with an unfavorable lipid profile. The lipoprotein particle number and size were then related to glycated hemoglobin (A1C), need for insulin treatment, gender, race/ethnicity, BMI, and blood pressure.
Over 3 years, study participants (n=348) demonstrated increasing numbers of low-density lipoprotein (LDL), high-density lipoprotein (HDL) and very low-density lipoprotein (VLDL) particles (all P < .001).
In addition, A1C was strongly correlated with LDL, VLDL, and HDL particle number (all P < .005), while BMI and blood pressure exhibited a positive association with LDL, HDL, and VLDL particle numbers. According to researchers, the “data demonstrate an atherogenic lipoprotein phenotype in youth with T2D and strong relationships with glycemic control and other cardiac risk factors,” prompting concern of premature development of atherosclerosis in youth with T2D.
Future health complications resulting from T2D or obesity in youth can be severe.
In a 10-year study following 989 individuals, researchers discovered over 65% of children with initial obesity remained obese at follow-up while only 10.4% of non-obese children at baseline became obese.4
According to investigators, “adipokine dysregulation is an early biomarker of adipose tissue dysfunction, which has been shown to relate to metabolic health.”
Data showed decreased adiponectin and fibroblast growth factor 21 (FGF-21) levels and increased leptin were associated with obesity risk at baseline and 10-year follow-up (all P < .05), suggesting “certain aberrant patterns of adipokine regulation during childhood may serve as biomarkers for the subsequent development of obesity.”
Individuals with diabetes are also at high risk for heart failure with preserved ejection fraction (HFpEF) due to diabetic cardiomyopathy (DCM). DCM is defined as abnormal myocardial structure and function without the presence of overt coronary artery disease, and the condition can lead to diastolic dysfunction.
Researchers compared the potential for long-term health complications in young adults with T2D and type 1 diabetes (T1D)5.
Of 255 study participants with T1D (mean age 21.2 [5.2]) and 203 with T2D (mean age 24.3[4.3]), all were diagnosed with diabetes in childhood and had an average disease duration of 11 years. Data showed individuals with T2D exhibited:
“Given there are no effective treatments for HFpEF, our data suggest targeting modifiable risk factors may be useful to prevent further diastolic dysfunction,” they concluded.
One potential solution to the myriad of health complications resulting from youth obesity and T2D is a school-based program that promotes healthy eating and improves lifestyles6. Using a sticker-based food diary and colorful 12-page story book to motivate young children to adopt a healthier diet, researchers in Sri Lanka devised a novel school-based program for children ages 5 to 7.
The program was broken down by week. In the first week, children self-monitored their daily food intake at home via the food diary and received a Smiley Face Score (SFS) based on how healthy each meal was. Throughout the second week, teachers read the children’s books “illustrating the physical and psychosocial effects of obesity and benefits of healthy lifestyle in a child friendly manner.” Children completed the food diary again in the third week. To measure the program’s efficacy in improving healthy eating and lifestyle, researchers compared SFS of weeks 1 and 3. Class teachers and parents also completed anonymous grade-response and open response questionnaires.
In total, 1029 students completed food diaries and improvement in healthy eating was demonstrated by a mean SFS increase of 11.7% from week 1 to week 3. The study yielded the additional following results:
“This novel program led to a demonstrable improvement in healthy lifestyle among 5 to 7-yearolds and was received favorably by parents and teachers,” researchers concluded. Encouraged by the favorable results, the Ministry of Education in Sri Lanka plans to implement the program nationwide throughout 2020-2021 school year, with an enrollment total of around 830,000 students.
References:
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More